Corporate/ Company Law (Mondaq)
The new Therapeutic Goods Amendment Bill 2005 (Cth) ( Bill ) 1 has far-reaching implications. The Bill will introduce: for the Therapeutic Goods Administration ( TGA ) to deal with manufacturers and sponsors not complying with the Therapeutic Goods Act 1989 ( Act ), as well as their 'executive officers'.

FDA approves Noven's ADHD patch (Miami Herald)
In a huge boost to profits, Noven Pharmaceuticals has received permission from FDA regulators to sell the first patch to treat children with attention deficit hyperactivity disorder, the Kendall drugmaker announced.